Brief: IDEAYA Biosciences Appoints Stu Dorman As Chief Commercial Officer
18/11/2024 12:04
Nov 18 (Reuters) - IDEAYA Biosciences Inc IDYA.O :
* IDEAYA BIOSCIENCES APPOINTS STU DORMAN AS CHIEF COMMERCIAL
OFFICER
Source text: ID:nPn9grMp2a
Further company coverage: IDYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IDEAYA Biosciences
See all newsBrief: Ideaya Biosciences And Servier Announce Data From Three Clinical Trials At Esmo 2026 Supporting The Potential Of Darovasertib To Become A Foundational New Therapy For Patients Across The Treatment Journey Of Uveal Melanoma
Brief: Ideaya Biosciences Announces The Promotion Of Dr. Michael White To President, Research And Development
Brief: Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ideaya Biosciences Inc Reports Results For The Quarter Ended June 30: Earnings Summary
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj